analyst
NASDAQ · ELVN
Enliven Therapeutics, Inc.
Healthcare · Biotechnology
$49.12
Up+$2.28 (+4.64%)
Updated Sep 17, 2026, 2:47 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.11B
- P/E ratio
- -9.76
- Dividend yield
- 0.00%
- 52-week range
- $26.70 – $62.32
- Volume
- 2.91M
- Avg. volume
- 581.23K
Price performance
ELVN price history
1M range · 0 trading sessions · Daily adjusted prices
ELVN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ELVN news
The latest Smart Investors Daily articles mentioning ELVN.
Stock researchCompany · Forecast
Loading stock research…